Meeting with the MHRA regarding future surveillance of women taking valproate

Activity: Internal positions, career professional development and otherOtherResearch

Description

The UK medications regulator the MHRA invited experts to consult on the establishing of a register to monitor the continued but restricted use of sodium valproate in women of childbearing age and the longer term outcome of the children exposed to that medication in the womb.
Period20182019

Keywords

  • Regulation
  • Teratology
  • Epilepsy
  • Pregnancy
  • Anti epileptic drugs
  • Neurodevelopment